About Us.

MEVAC is a global pioneer in animal health, dedicated to advancing science-driven vaccines and diagnostic solutions. As a subsidiary of Kemin, we combine cutting-edge research with sustainable practices to protect livestock, poultry, and aquaculture.

```

History

From a single facility to a global presence in 42+ countries, MEVAC's growth reflects our unwavering dedication to innovation and impact.

Auto moving timeline

2006

The MEVAC idea is born

The beginning of MEVAC's journey toward building a leading veterinary vaccine company.

2011

First production facility

MEVAC launches its first production facility, B1, in Egypt.

2014

Production expansion

New production capacities were introduced to support the growing veterinary market.

2017

International growth

MEVAC strengthens its global presence and expands its international distribution network.

2020

B2 facility expansion

Expansion with the B2 facility, adding poultry vaccine production lines.

2022

KEMIN partnership

A strategic partnership supporting innovation, technology and international growth.

2024

42+ countries

MEVAC products become available across more than 42 countries worldwide.

2026

A new era of growth

MEVAC continues investing in quality, innovation and advanced vaccine technologies.

← Swipe to explore →

Since 2022, MEVAC partners with Kemin Industries, a global leader in biotechnology This partnership fuels our: R&D Advancements: With Kemin’s scientific expertise and resources.
Global Reach: Leveraging Kemin’s distribution networks to expand into new markets. Sustainability: Shared commitment to eco friendly production and animal welfare

Vision

MEVAC crafts science-driven vaccines and services that sustain the heartbeat of animal and human health, empowering a safer, healthier world and transforming the quality of life through innovation and care.

Mission

Crafting Science-Driven Solutions

To continuously develop vaccines and services grounded in cutting-edge science, tailored to the evolving needs of animal and human health. To improve customer journey through efficient, sustainable solutions achieving customer satisfaction.

Agile R&D

To lead with agile research and development practices with rapid response to emerging health challenges and drive impactful innovation.

Ensuring Uncompromising Quality

To uphold the highest global standards in quality, safety, and efficacy across all our vaccines and services, ensuring trust and protection at every step with sustainability compliance.